BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33543405)

  • 1. Generative chemistry: drug discovery with deep learning generative models.
    Bian Y; Xie XQ
    J Mol Model; 2021 Feb; 27(3):71. PubMed ID: 33543405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico.
    Kadurin A; Nikolenko S; Khrabrov K; Aliper A; Zhavoronkov A
    Mol Pharm; 2017 Sep; 14(9):3098-3104. PubMed ID: 28703000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular
    Lin E; Lin CH; Lane HY
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular design in drug discovery: a comprehensive review of deep generative models.
    Cheng Y; Gong Y; Liu Y; Song B; Zou Q
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning tools to accelerate antibiotic discovery.
    Cesaro A; Bagheri M; Torres M; Wan F; de la Fuente-Nunez C
    Expert Opin Drug Discov; 2023; 18(11):1245-1257. PubMed ID: 37794737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
    Mouchlis VD; Afantitis A; Serra A; Fratello M; Papadiamantis AG; Aidinis V; Lynch I; Greco D; Melagraki G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery.
    Saikin SK; Kreisbeck C; Sheberla D; Becker JS; A AG
    Expert Opin Drug Discov; 2019 Jan; 14(1):1-4. PubMed ID: 30488727
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in Deep Learning for Property-driven Drug Design.
    Born J; Manica M
    Curr Med Chem; 2021; 28(38):7862-7886. PubMed ID: 34325627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Progress of Deep Learning in Drug Discovery.
    Wang F; Diao X; Chang S; Xu L
    Curr Pharm Des; 2021; 27(17):2088-2096. PubMed ID: 33511933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generative Models for De Novo Drug Design.
    Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
    J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities.
    Gangwal A; Ansari A; Ahmad I; Azad AK; Kumarasamy V; Subramaniyan V; Wong LS
    Front Pharmacol; 2024; 15():1331062. PubMed ID: 38384298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.